Delivery Order 75N98026D00031-75N98026F00002
Award Date 7/20/26
Potential Completion Date 1/19/28
Potential Value $478K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Kansas City, MO 64110, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $5,108,214.00 cost-plus-award-fee delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) with an ultimate completion date of September 18, 2029. Mriglobal has been awarded multiple significant federal contracts and grants, including Indefinite Delivery Contracts...
- The National Institute on Drug Abuse issued a $131,900 delivery order to Mriglobal (doing business as Midwest Research Institute) on June 3, 2022, under the CRO Support for NCATS Drug Substance Development and Manufacture contract for stability studies on ML-246 (METARRESTIN) and contract research organization support for drug substance development and manufacture. Place of performance is Kansas City, MO. The order is firm fixed price with an ultimate completion date of January 30, 2028. No...
- This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. Department of Health and Human Services, to Mriglobal (doing business as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract is part of NIDA's Drug Manufacturing and Formulation Program (DMFP) and is for small-scale testing of convergent route processes. The contract has a ceiling value of $942,363.89 and does not have a set-aside...
- The National Institute on Drug Abuse issued a $1,838,614.86 delivery order to Altasciences Clinical Kansas Inc. on September 25, 2023, for pharmacokinetic and pharmacodynamic trials supporting Phase 1 cocaine drug interaction studies in medication development for substance use disorders. The order runs through October 22, 2025. Place of performance is Shawnee Mission, Kansas. The delivery order is priced on a firm fixed-price basis and was issued under a $21 million single-award indefinite...
- The National Institute of Neurological Disorders and Stroke issued a delivery order to Mriglobal (doing business as Midwest Research Institute) on January 15, 2015, under the Drug Manufacturing and Formulation Program (DMFP) with a ceiling value of $514,881.25. The order, which was cost-plus-fixed-fee priced and required de-obligation of unexpended fiscal year 2020 funding by September 30, 2025, called for technical support under Performance Activity 1 with an ultimate completion date of January...
- The National Institutes of Health National Center for Advancing Translational Sciences awarded a $594,882 delivery order contract to Midwest Research Institute, doing business as Mriglobal, for Analytical Method Development, Validation and Stability Study of ORC-13661. This delivery order was issued against the prime contractor's master indefinite-delivery indefinite-quantity contract for Contract Research Organization Support for Drug Substance Development and Manufacture. Performance will take...
- The National Institute of Neurological Disorders and Stroke issued a delivery order to Mriglobal (doing business as Midwest Research Institute) on September 16, 2019, under the Drug Manufacturing and Formulation Program (DMFP) with a ceiling value of $2,412,219.51. The order was administratively de-obligated on September 30, 2025, to close expired fiscal year 2020 funding in accordance with 31 U.S.C. Section 1552(a), with an ultimate completion date of January 31, 2027. Place of performance is...
- This is a $99,500.00 delivery order contract awarded to Mriglobal, also doing business as Midwest Research Institute, by the Department of Health and Human Services' National Institutes of Health National Institute on Aging. The contract is for drug toxicity testing services, with a period of performance through July 31, 2024. The contract is not set aside for any small business program. Mriglobal is a 501(c)(3) non-profit research organization that specializes in scientific research, testing,...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a non-profit research organization. The contract is valued at $949,295.00 and will run through January 31, 2026. The contract is for the evaluation of the shelf-life of samples of investigational clinical drug formulations, including parenteral, oral, and other dosage...
- The National Cancer Institute awarded a delivery order valued at $2.79 million to Mriglobal (doing business as Midwest Research Institute) on September 25, 2024, for the manufacture of plasmid DNA drug substance and drug product. This contract, which is not subject to any small business set-aside designation, is structured as a cost-plus-no-fee arrangement with a completion date of April 30, 2028, and will be performed in Rockville, Maryland. Plasmid DNA represents an important class of...